BofA Securities Reiterates Buy Rating on Agios Pharma (AGIO) After Positive Conference Presentation
Tweet Send to a Friend
BofA Securities analyst Greg Harrison reiterated a Buy rating and $54.00 price target on Agios Pharma (NASDAQ: AGIO) after management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
